Audeara Secures $164K in Orders as Clinico White-Label Partnership Scales
Audeara secures $164,000 in purchase orders as Clinico partnership scales
Audeara Limited (ASX: AUA) has received purchase orders totalling approximately $164,000 from Clinico Inc., marking the commencement of three white-label commercial programs. The Audeara Auracast Clinico Partnership Expansion builds on the successful October 2024 launch of Clinico Sound Earbuds CS1 in Taiwan and validates the company’s AUA Technology integration model for international scaling.
Two of the three programs incorporate Auracast-enabled devices featuring Audeara’s BT-03 Audio Broadcaster technology, with the third covering Clinico-branded packaging, accessories and programming tools. This repeat customer engagement demonstrates commercial traction beyond initial pilot deployments, with the white-label model enabling scalable revenue generation without direct-to-consumer marketing costs.
When big ASX news breaks, our subscribers know first
What is Auracast and why it matters for audio technology investors
Auracast is a shared audio standard built on Bluetooth LE Audio technology. It enables compatible personal listening devices to receive audio streams broadcast from a central source without individual pairing, supporting scalable shared listening experiences in public and commercial environments.
The technology requires a two-part ecosystem. Broadcast infrastructure transmits the audio signal, whilst compatible listening devices receive it. Audeara addresses both components, with the BT-03 Audio Broadcaster providing infrastructure and products like Audeara Buds and Audio Transceivers serving as compatible listening devices.
This platform approach creates multiple revenue streams from a single technology investment whilst positioning the company as an early mover in emerging Auracast infrastructure markets. The dual-sided offering differentiates Audeara from competitors focused exclusively on either infrastructure or end-user devices.
BT-03 Audio Broadcaster launches at $399 with global certification underway
The BT-03 Audio Broadcaster has launched in Australia at a recommended retail price of $399, establishing a baseline average selling price for revenue modelling. Certification processes are underway for the United States, Japan, Taiwan, Canada and the European Union, creating pathways to material international addressable markets.
The device has been designed to integrate seamlessly with existing AV systems, enable scalable deployment across multi-room and multi-venue environments, and support enhanced listening experiences for all users. Early channel validation has been achieved through stocking by leading AV installers and consumer audio retailers in Australia.
Target deployment environments include:
- Universities and education providers
- Clinical and aged care settings
- Hospitality and entertainment venues
- Schools and training facilities
International distributors are preparing to onboard the product following completion of certification processes, supporting the company’s strategy to scale beyond the domestic market.
Clinico programs demonstrate white-label integration model
The three programs covered by the $164,000 purchase orders represent proof of concept for embedding Audeara technology within partner ecosystems. This approach enables the company to leverage established distribution channels without bearing direct market entry costs.
| Program | Description | Strategic Value |
|---|---|---|
| Auracast Device #1 | BT-03 Broadcaster white-label | Infrastructure deployment |
| Auracast Device #2 | Second Auracast-enabled device | Product range expansion |
| Accessories & Packaging | Clinico-branded accessories | Ecosystem completion |
The Clinico relationship validates the replicability of this model for additional international partners. White-label integration provides capital-efficient scaling through established partner channels, particularly in regions where Audeara lacks direct distribution infrastructure.
CEO commentary signals growing global appetite
The Audeara Auracast Clinico Partnership Expansion follows recent management engagement at Integrated System Europe in Barcelona, where Dr James Fielding met with global Auracast product leaders. This industry engagement supports pipeline development narratives and positions the company within broader Auracast ecosystem momentum.
Dr James Fielding, Managing Director and CEO
“Having just returned from Integrated System Europe in Barcelona, meeting with a number of global Auracast product leaders, it was clear that there is a growing appetite for our technology offering, leaving Audeara very well placed to capitalise on the opportunity to transform listening and communication experiences.”
The company’s Auracast transmitters are reportedly already deployed throughout leading global universities, with the Clinico programs representing the next step in scaling that infrastructure through white-label integration to target consumer markets.
The next major ASX story will hit our subscribers first
Revenue diversification through platform model
Audeara’s AUA Technology division strategy centres on three pillars designed to reduce single-product concentration risk:
- Embedding Auracast broadcast and audio DSP capabilities into partner product lines
- Expanding white-label and co-branded programs internationally
- Leveraging infrastructure deployment to drive broader Auracast ecosystem adoption
This integrated platform model positions the company as a technology partner rather than a competing hardware vendor. The approach supports diversified revenue growth by enabling multiple commercialisation pathways from the same underlying technology platform.
The Clinico programs demonstrate how this strategy translates into commercial outcomes. Rather than competing directly in Taiwan’s consumer audio market, Audeara supplies technology to an established regional partner with existing distribution networks, customer relationships and market knowledge. This capital-light approach enables international expansion without the working capital requirements typically associated with direct market entry.
Purchase orders received to date reflect the continued commercial progression of the partnership and the sales growth potential of Auracast-enabled solutions into additional markets and deployment environments. The company believes this integrated platform model supports diversified revenue growth and positions Audeara as a scalable Auracast technology partner globally.
Want the Next Consumer Tech Winner in Your Inbox?
Join 20,000+ investors receiving FREE breaking ASX news with in-depth analysis delivered within minutes of release. Click the “Free Alerts” button at StockWire X to get market-moving Consumer Discretionary announcements the moment they drop, complete with expert coverage you can act on immediately.